Patents by Inventor Ji-Yong Yoon
Ji-Yong Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10949364Abstract: A multi-processor system includes a first processor; a second processor; a common memory configured to store data generated by the first processor and data generated by the second processor; and a memory interface circuit configured to interface between the common memory and the first and second processors, the first processor being configured to demodulate and decode a signal received through wireless communication, and store the decoded data in the common memory via the memory interface circuit, the memory interface circuit being configured to read and decipher the decoded data stored in the common memory, and store the deciphered data in the common memory.Type: GrantFiled: October 22, 2019Date of Patent: March 16, 2021Assignee: Samsung Electronics Co., Ltd.Inventor: Ji Yong Yoon
-
Patent number: 10808272Abstract: Provided are a method of preparing an antibody with a regulated, sugar chain content, the method including the step of culturing antibody-expressing cells in a medium including glycerol as an additive for regulating the antibody sugar chain content, a method of preparing a high-quality population of antibodies by regulating the sugar content of the antibody to a desired content, and a population of antibodies prepared by the method. Further, provided is a method of regulating the antibody sugar chain content, the method including the step of culturing antibody-expressing cells in a medium including glycerol as an additive for regulating the antibody sugar chain content. Furthermore, provided is a medium composition, for regulating the antibody sugar chain content, the medium composition including glycerol as an additive for regulating the antibody sugar chain content.Type: GrantFiled: April 2, 2015Date of Patent: October 20, 2020Assignee: Prestige Biopharma PTE. LTD.Inventors: Jae Young Chang, Eun Ho Hwang, Yong Jin Kim, Won Kyum Kim, Sang Kyung Park, Jun Yong Park, Kyo Eun Ahn, Yong Ho Ahn, Ji Yong Yoon, Jung Woo Lee
-
Patent number: 10628159Abstract: A processor includes; a processor core, a register selectively controlled by either external hardware during a first operation mode or the processor core during a second operation mode, and a selection circuit receiving first data provided by the external hardware to the register during the first operation mode and second data provided by the processor core to the register during the second operation mode.Type: GrantFiled: September 28, 2017Date of Patent: April 21, 2020Assignee: Sansung Electronics Co., Ltd.Inventor: Ji Yong Yoon
-
Publication number: 20200050560Abstract: A multi-processor system includes a first processor; a second processor; a common memory configured to store data generated by the first processor and data generated by the second processor; and a memory interface circuit configured to interface between the common memory and the first and second processors, the first processor being configured to demodulate and decode a signal received through wireless communication, and store the decoded data in the common memory via the memory interface circuit, the memory interface circuit being configured to read and decipher the decoded data stored in the common memory, and store the deciphered data in the common memory.Type: ApplicationFiled: October 22, 2019Publication date: February 13, 2020Applicant: Samsung Electronics Co., Ltd.Inventor: Ji Yong YOON
-
Patent number: 10482042Abstract: A multi-processor system includes a first processor; a second processor; a common memory configured to store data generated by the first processor and data generated by the second processor; and a memory interface circuit configured to interface between the common memory and the first and second processors, the first processor being configured to demodulate and decode a signal received through wireless communication, and store the decoded data in the common memory via the memory interface circuit, the memory interface circuit being configured to read and decipher the decoded data stored in the common memory, and store the deciphered data in the common memory.Type: GrantFiled: December 7, 2018Date of Patent: November 19, 2019Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventor: Ji Yong Yoon
-
Publication number: 20190108146Abstract: A multi-processor system includes a first processor; a second processor; a common memory configured to store data generated by the first processor and data generated by the second processor; and a memory interface circuit configured to interface between the common memory and the first and second processors, the first processor being configured to demodulate and decode a signal received through wireless communication, and store the decoded data in the common memory via the memory interface circuit, the memory interface circuit being configured to read and decipher the decoded data stored in the common memory, and store the deciphered data in the common memory.Type: ApplicationFiled: December 7, 2018Publication date: April 11, 2019Applicant: Samsung Electronics Co., Ltd.Inventor: Ji Yong YOON
-
Patent number: 10185673Abstract: A multi-processor system includes a first processor; a second processor; a common memory configured to store data generated by the first processor and data generated by the second processor; and a memory interface circuit configured to interface between the common memory and the first and second processors, the first processor being configured to demodulate and decode a signal received through wireless communication, and store the decoded data in the common memory via the memory interface circuit, the memory interface circuit being configured to read and decipher the decoded data stored in the common memory, and store the deciphered data in the common memory.Type: GrantFiled: November 7, 2016Date of Patent: January 22, 2019Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventor: Ji Yong Yoon
-
Publication number: 20180189059Abstract: A processor includes; a processor core, a register selectively controlled by either external hardware during a first operation mode or the processor core during a second operation mode, and a selection circuit receiving first data provided by the external hardware to the register during the first operation mode and second data provided by the processor core to the register during the second operation mode.Type: ApplicationFiled: September 28, 2017Publication date: July 5, 2018Inventor: JI YONG YOON
-
Patent number: 9683012Abstract: The present invention relates to a method for preparing a population of antibodies to have high purity and high quality by removing antibody isoforms and impurities through the use of a cation exchange column, a hydrophobic interaction column, and an anion exchange column successively, without using a protein A column; and to a population of antibodies prepared by the above method.Type: GrantFiled: December 14, 2012Date of Patent: June 20, 2017Assignee: PRESTIGE BIOPHARMA PTE. LTD.Inventors: Ji Yong Yoon, Dong Eun Lee, Won Kyum Kim, Jeong Won Youn, Jung Eun Baek
-
Publication number: 20170139850Abstract: A multi-processor system includes a first processor; a second processor; a common memory configured to store data generated by the first processor and data generated by the second processor; and a memory interface circuit configured to interface between the common memory and the first and second processors, the first processor being configured to demodulate and decode a signal received through wireless communication, and store the decoded data in the common memory via the memory interface circuit, the memory interface circuit being configured to read and decipher the decoded data stored in the common memory, and store the deciphered data in the common memory.Type: ApplicationFiled: November 7, 2016Publication date: May 18, 2017Applicant: Samsung Electronics Co., Ltd.Inventor: Ji Yong YOON
-
Publication number: 20170107551Abstract: Provided are a method of preparing an antibody with a regulated, sugar chain content, the method including the step of culturing antibody-expressing cells in a medium including glycerol as an additive for regulating the antibody sugar chain content, a method of preparing a high-quality population of antibodies by regulating the sugar content of the antibody to a desired content, and a population of antibodies prepared by the method. Further, provided is a method of regulating the antibody sugar chain content, the method including the step of culturing antibody-expressing cells in a medium including glycerol as an additive for regulating the antibody sugar chain content. Furthermore, provided is a medium composition, for regulating the antibody sugar chain content, the medium composition including glycerol as an additive for regulating the antibody sugar chain content.Type: ApplicationFiled: April 2, 2015Publication date: April 20, 2017Applicant: Prestige Biopharma PTE. LTD.Inventors: Jae Young Chang, Eun Ho Hwang, Yong Jin Kim, Won Kyum Kim, Sang Kyung Park, Jun Yong Park, Kyo Eun Ahn, Yong Ho Ahn, Ji Yong Yoon, Jung Woo Lee
-
Patent number: 8972768Abstract: An apparatus and a method for scaling a dynamic bus clock are provided. The apparatus for scaling the dynamic bus clock includes at least one master module, at least one slave module, a bus for delivering data transmitted and received by the at least one master module and the at least one slave module, a bus frequency controller for determining a bus clock frequency by considering activity information of the at least one master module, and a clock generator for generating the frequency as determined by the bus frequency controller and providing the generated frequency to the at least one master module, the at least one slave module, and the bus.Type: GrantFiled: November 3, 2010Date of Patent: March 3, 2015Assignee: Samsung Electronics Co., Ltd.Inventors: Kang-Min Lee, Ji-Yong Yoon
-
Patent number: 8924753Abstract: An apparatus and method for adaptively changing clock frequencies of a Central Processing Unit (CPU) and a bus in a digital system are provided. The system includes an Adaptive Frequency Scaling (AFS) controller and a clock controller. The AFS controller determines whether to change a clock frequency of the CPU according to operation information of the CPU, and determines whether to change a clock frequency of the bus according to operation information of the bus. The clock controller generates a clock frequency of the CPU and a clock frequency of the bus according to the determination of the AFS controller.Type: GrantFiled: October 19, 2011Date of Patent: December 30, 2014Assignee: Samsung Electronics Co., Ltd.Inventors: Tae-Hong Park, Ji-Yong Yoon, Kang-Min Lee, Yun-Ju Kwon, Jong-Hyuck Hong
-
Publication number: 20140316115Abstract: The present invention relates to a method for preparing a population of antibodies to have high purity and high quality by removing antibody isoforms and impurities through the use of a cation exchange column, a hydrophobic interaction column, and an anion exchange column successively, without using a protein A column; and to a population of antibodies prepared by the above method.Type: ApplicationFiled: December 14, 2012Publication date: October 23, 2014Applicant: Hanwha Chemical CorporationInventors: Ji Yong Yoon, Dong Eun Lee, Won Kyum Kim, Jeong Won Youn, Jung Eun Baek
-
Patent number: 8715670Abstract: The present invention relates to a human monoclonal antibody that specifically binds to VCAM-1, and a therapeutic composition for the treatment of inflammatory disease or cancer comprising the same. The human monoclonal antibody according to the present invention shows a strong affinity to VCAM-1 expressed on human or mouse endothelial cell, effectively inhibits leukocyte adhesion to activated endothelial cells expressing VCAM-1, and shows a low immunogenicity, thereby being used for the treatment of cancer or inflammatory disease such as asthma, rhinitis, arthritis, multiple sclerosis, bowel disease, arteriosclerosis, myocardial infarction and transplant rejection.Type: GrantFiled: March 31, 2010Date of Patent: May 6, 2014Assignee: Hanwha Chemical CorporationInventors: Jung Tae Lee, Kyung Duk Moon, Ji Yong Yoon, Byung Je Sung, Dong Heon Lee, Il Sun Lee, Dong Eun Lee, Su Yeon Ryu, Young Woo Park, So Young Choi, Ji Hyun Park, Myeoung Hee Jang
-
Patent number: 8623368Abstract: The present invention relates to a human recombinant monoclonal antibody that specifically binds to human Vascular Cell Adhesion Molecule-1 (VCAM-1) to inhibit adhesion between leukocytes and activated endothelial cells and transmigration of leukocytes through the activated endothelial cells, and a prophylactic and therapeutic composition for inflammatory disease or cancer comprising the same. The human recombinant monoclonal antibody according to the present invention shows a strong affinity to VCAM-1 expressed on human endothelial cell, and effectively inhibits VCAM-1-mediated adhesion between leukocytes and activated endothelial cells and transmigration of leukocytes through the activated endothelial cells, thereby being used for the prevention and treatment of inflammatory disease such as asthma and arthritis, transplant rejection, cardiovascular disease, and cancer.Type: GrantFiled: October 22, 2010Date of Patent: January 7, 2014Assignee: Hanwha Chemical CorporationInventors: Jung Tae Lee, Kyung Duk Moon, Ji Yong Yoon, Byung Je Sung, Dong Heon Lee, Dong Eun Lee, Su Yeon Ryu, Hyun Bo Shim, Kyung Jae Kang
-
Publication number: 20120308574Abstract: The present invention relates to a human monoclonal antibody that specifically binds to VCAM-1, and a therapeutic composition for the treatment of inflammatory disease or cancer comprising the same. The human monoclonal antibody according to the present invention shows a strong affinity to VCAM-1 expressed on human or mouse endothelial cell, effectively inhibits leukocyte adhesion to activated endothelial cells expressing VCAM-1, and shows a low immunogenicity, thereby being used for the treatment of cancer or inflammatory disease such as asthma, rhinitis, arthritis, multiple sclerosis, bowel disease, arteriosclerosis, myocardial infarction and transplant rejection.Type: ApplicationFiled: March 31, 2010Publication date: December 6, 2012Applicant: HANWHA CHEMICAL CORPORATIONInventors: Jung Tae Lee, Kyung Duk Moon, Ji Yong Yoon, Byung Je Sung, Dong Heon Lee, Il Sun Lee, Dong Eun Lee, Su Yeon Ryu, Young Woo Park, So Young Choi, Ji Hyun Park, Myeoung Hee Jang
-
Publication number: 20120276091Abstract: The present invention relates to a human recombinant monoclonal antibody that specifically binds to human Vascular Cell Adhesion Molecule-1 (VCAM-1) to inhibit adhesion between leukocytes and activated endothelial cells and transmigration of leukocytes through the activated endothelial cells, and a prophylactic and therapeutic composition for inflammatory disease or cancer comprising the same. The human recombinant monoclonal antibody according to the present invention shows a strong affinity to VCAM-1 expressed on human endothelial cell, and effectively inhibits VCAM-1-mediated adhesion between leukocytes and activated endothelial cells and transmigration of leukocytes through the activated endothelial cells, thereby being used for the prevention and treatment of inflammatory disease such as asthma and arthritis, transplant rejection, cardiovascular disease, and cancer.Type: ApplicationFiled: October 22, 2010Publication date: November 1, 2012Applicant: HANWHA CHEMICAL CORPORATIONInventors: Jung Tae Lee, Kyung Duk Moon, Ji Yong Yoon, Byung Je Sung, Dong Heon Lee, Dong Eun Lee, Su Yeon Ryu, Hyun Bo Shim, Kyung Jae Kang
-
Publication number: 20120102345Abstract: An apparatus and method for adaptively changing clock frequencies of a Central Processing Unit (CPU) and a bus in a digital system are provided. The system includes an Adaptive Frequency Scaling (AFS) controller and a clock controller. The AFS controller determines whether to change a clock frequency of the CPU according to operation information of the CPU, and determines whether to change a clock frequency of the bus according to operation information of the bus. The clock controller generates a clock frequency of the CPU and a clock frequency of the bus according to the determination of the AFS controller.Type: ApplicationFiled: October 19, 2011Publication date: April 26, 2012Applicant: SAMSUNG ELECTRONICS CO. LTD.Inventors: Tae-Hong PARK, Ji-Yong YOON, Kang-Min LEE, Yun-Ju KWON, Jong-Hyuck HONG
-
Publication number: 20110106992Abstract: An apparatus and a method for scaling a dynamic bus clock are provided. The apparatus for scaling the dynamic bus clock includes at least one master module, at least one slave module, a bus for delivering data transmitted and received by the at least one master module and the at least one slave module, a bus frequency controller for determining a bus clock frequency by considering activity information of the at least one master module, and a clock generator for generating the frequency as determined by the bus frequency controller and providing the generated frequency to the at least one master module, the at least one slave module, and the bus.Type: ApplicationFiled: November 3, 2010Publication date: May 5, 2011Applicant: SAMSUNG ELECTRONICS CO. LTD.Inventors: Kang-Min LEE, Ji-Yong YOON